Overview
Teicoplanin is a glycopeptide antibiotic consisting of a mixture of several compounds, five major (named teicoplanin A2-1 through A2-5) and four minor (named teicoplanin RS-1 through RS-4). All teicoplanins share a same glycopeptide core, teicoplanin A3-1, but differ in the length and conformation of side chains attached to their β-D-glucosamine moiety.
Indication
For the treatment of bacterial infections caused by susceptible microorganisms.
Associated Conditions
- Angina Pectoris
- Anginal Pain
- Bacteremia
- Bloodstream Infections (BSI)
- Bone and Joint Infections
- Clostridium Difficile
- Clostridium Difficile Infection (CDI)
- Community Acquired Pneumonia (CAP)
- Complicated Urinary Tract Infection
- Infective Endocarditis (IE)
- Lower Respiratory Tract and Lung Infections
- Non-complicated Skin and Soft Tissue Infections
- Nosocomial Pneumonia
- Peritonitis
- Skin and Soft Tissue Infections (SSTIs)
- Urinary Tract Infection
Clinical Trials
View More Clinical Trials
Sign in to access the complete clinical trial database with detailed study information.
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2012/05/04 | Phase 4 | UNKNOWN | Clinica Universidad de Navarra, Universidad de Navarra | ||
2009/06/19 | Phase 1 | Withdrawn | Aarhus University Hospital | ||
2008/07/21 | Phase 4 | Completed | University of Athens | ||
2007/04/19 | N/A | Completed | PETHEMA Foundation | ||
2007/03/30 | Phase 4 | Completed | |||
2007/02/02 | Phase 3 | Terminated | |||
2007/01/30 | Phase 2 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | ||
2006/08/24 | Phase 4 | UNKNOWN |
FDA Drug Approvals
View More FDA Approvals
Sign in to access additional FDA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
View More EMA Approvals
Sign in to access additional EMA-approved drug information with detailed regulatory data.
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
View More HSA Approvals
Sign in to access additional HSA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
View More NMPA Approvals
Sign in to access additional NMPA-approved drug information with detailed regulatory data.
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Teicoplanin for Injection | 国药准字H20249316 | 化学药品 | 注射剂 | 11/15/2024 | |
| Teicoplanin for Injection | 国药准字H20249205 | 化学药品 | 注射剂 | 10/29/2024 | |
| Teicoplanin for Injection | 国药准字H20247194 | 化学药品 | 注射剂 | 8/22/2024 | |
| Teicoplanin for Injection | 国药准字H20093651 | 化学药品 | 注射剂 | 10/22/2023 |
PPB Drug Approvals
View More PPB Approvals
Sign in to access additional PPB-approved drug information with detailed regulatory data.
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
View More TGA Approvals
Sign in to access additional TGA-approved drug information with detailed regulatory data.
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.